T2 Biosystems, Inc. (TTOO) Financials

TTOO Assets vs Liabilities
DateAssetsLiabilities
Sept. 30, 2024 18.1 million 29.8 million
June 30, 2024 21.7 million 27.6 million
March 31, 2024 24.8 million 62.5 million
Dec. 31, 2023 34.8 million 62.8 million

TTOO Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
Sept. 30, 2024 -6.3 million 216000
June 30, 2024 -9.2 million 196000
March 31, 2024 -11.7 million 1.6 million
Dec. 31, 2023 -9.4 million 728000

TTOO Net Income

No data available :(

TTOO Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
Sept. 30, 2024 2.1 million 5.3 million 7.0 million
June 30, 2024 4.2 million 5.7 million 7.4 million
March 31, 2024 6.2 million 6.2 million 7.8 million
Dec. 31, 2023 15.7 million 6.6 million 8.2 million

TTOO Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
Sept. 30, 2024 17.9 million
June 30, 2024 14.1 million
March 31, 2024 5.1 million
Dec. 31, 2023 4.1 million

TTOO Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
Sept. 30, 2024 - 2.7 million 5.4 million -
June 30, 2024 - 3.4 million 5.5 million -
March 31, 2024 26000 3.7 million 6.7 million -
Dec. 31, 2023 26000 3.1 million 5.3 million -

TTOO Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
Sept. 30, 2024 2.0 million 4.1 million
June 30, 2024 2.0 million 2.7 million
March 31, 2024 2.1 million 4.2 million
Dec. 31, 2023 1.7 million 2.6 million

TTOO Revenue by Segment
Graph available only for paid members. Upgrade to see it.

TTOO

Price: $0

52 week price:
0.00
0.18

Earnings Per Share: -0.03 USD

P/E Ratio: -0.10

Exchange: NCM

Sector: Healthcare

Industry: Diagnostics & Research

Country: United States

Volume: 168600

Ebitda: -11.7 million

Market Capitalization: 14023

Links: